investorscraft@gmail.com

Biofrontera Inc. (BFRI)

Previous Close
$0.70
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)44.956321
Intrinsic value (DCF)0.00-100
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

120 Presidential Way
Woburn, MA 01801
United States
Phone: 781 245 1325
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: Dr. Hermann Luebbert Ph.D.
Full Time Employees: 92

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

HomeMenuAccount